In consideration of these compelling findings, we undertook meticulous survival analyses predicated upon the levels of GLIPR2+ infiltration within the cohorts of LUAD and LUSC patients derived from Nantong Tumor Hospital. This evidence concerns the gene GLIPR2 and neoplasm.